Widespread dissemination of a drug-susceptible strain of Mycobacterium tuberculosis

被引:65
|
作者
Friedman, CR
Quinn, GC
Kreiswirth, BN
Perlman, DC
Salomon, N
Schluger, N
Lutfey, M
Berger, J
Poltoratskaia, N
Riley, LW
机构
[1] CORNELL UNIV MED COLL,DEPT MED,NEW YORK,NY
[2] NYU,BELLEVUE HOSP CTR,NEW YORK,NY 10016
[3] BETH ISRAEL MED CTR,DEPT MED,NEW YORK,NY 10003
[4] ST BARNABAS HOSP,PUBL HLTH RES INST,TB CTR,NEW YORK,NY
[5] ST BARNABAS HOSP,DEPT MED,NEW YORK,NY
来源
JOURNAL OF INFECTIOUS DISEASES | 1997年 / 176卷 / 02期
关键词
D O I
10.1086/514067
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
In New York City, a large proportion of new tuberculosis cases has been caused by 1 drug-susceptible strain (called C strain) of Mycobacterium tuberculosis, Between 1991 and 1994, among >600 tuberculosis patients consecutively identified in four large hospitals in the city, 54 with C strain, 69 with non-C Cluster pattern strains, and 42 with noncluster pattern strains were studied, Susceptibility to reactive nitrogen intermediates (RNI) of selected isolates was compared, In a case-control analysis, 51% of patients with C strain, 28% with non-C cluster strains (P<.05), and 14% with noncluster strains (P<.01) were found to be injection drug users, C strain but not 13 other unrelated isolates were resistant to RNI, Injection drug use may provide a selective pressure for an RNI-resistant tubercle bacillus to emerge, which may give the organism a biologic advantage and explain the widespread dissemination of C strain M. tuberculosis within the city.
引用
收藏
页码:478 / 484
页数:7
相关论文
共 50 条
  • [1] Unsuspected and extensive transmission of a drug-susceptible Mycobacterium tuberculosis strain
    López-Calleja A.I.
    Gavín P.
    Antonia M.A.
    Vitoria Ma.A.
    Iglesias Ma.J.
    Guimbao J.
    Lázaro Ma.Á.
    Rastogi N.
    Revillo Ma.J.
    Martín C.
    Samper S.
    BMC Pulmonary Medicine, 9 (1)
  • [2] Linezolid for drug-susceptible tuberculosis
    Han, Jiyeon
    Yim, Jae-Joon
    LANCET INFECTIOUS DISEASES, 2019, 19 (05): : 468 - 469
  • [3] Drug-susceptible tuberculosis - Reply
    Friedman, DR
    Quinn, GC
    Kreiswirth, BN
    Perlman, DC
    Saloman, N
    Schluger, N
    Lutfey, M
    Berger, J
    Poltoratskaia, N
    Riley, LW
    JOURNAL OF INFECTIOUS DISEASES, 1998, 177 (04): : 1138 - 1139
  • [4] Treatment of Drug-Susceptible Tuberculosis
    Dela Cruz, Charles S.
    Lyons, Patrick G.
    Pasnick, Susan
    Weinstock, Tanya
    Nahid, Payam
    Wilson, Kevin C.
    Thomson, Carey C.
    ANNALS OF THE AMERICAN THORACIC SOCIETY, 2016, 13 (11) : 2060 - 2063
  • [5] Linezolid for drug-susceptible tuberculosis
    Bilgin, Huseyin
    Tukenmez-Tigen, Elif
    LANCET INFECTIOUS DISEASES, 2019, 19 (04): : 357 - 357
  • [6] Drug-Susceptible and Multidrug-Resistant Mycobacterium tuberculosis in a Single Patient
    Baffoe-Bonnie, Anthony
    Houpt, Eric R.
    Turner, Lauren
    Dodge, Denise
    Heysell, Scott K.
    EMERGING INFECTIOUS DISEASES, 2019, 25 (11) : 2120 - 2121
  • [7] Transmission of drug-susceptible and drug-resistant mycobacterium tuberculosis among households contacts
    Morcillo, Nora
    Imperiale, Belen
    Di Giulio, Beatriz
    Zumarraga, Martin
    Cataldi, Angel
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42
  • [8] Simultaneous infection with two drug-susceptible Mycobacterium tuberculosis strains in an immunocompetent host
    Pavlic, M
    Allerberger, F
    Dierich, MP
    Prodinger, WM
    JOURNAL OF CLINICAL MICROBIOLOGY, 1999, 37 (12) : 4156 - 4157
  • [9] RISK FACTORS FOR UNFAVORABLE OUTCOMES IN DRUG-SUSCEPTIBLE MYCOBACTERIUM TUBERCULOSIS TREATMENT IN UGANDA
    Harper, Michael S.
    Zawedde-Muyanja, Stella
    Manabe, Yukari
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2019, 101 : 366 - 366
  • [10] Molecular typing of drug-susceptible and -resistant Mycobacterium tuberculosis in Johannesburg, South Africa
    Kamudumuli, P. S.
    Beylis, N.
    Blann, L.
    Duset, A.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2015, 19 (07) : 834 - 840